Celgene announces additional $3 billion share repurchase authorization
Celgene announced the Company's Board of Directors authorized the repurchase of an additional $3 billion of the Company's common stock. In addition, the Company plans to enter into an accelerated share repurchase agreement to repurchase an aggregate of $2 billion of the Company's common stock. May 24, 2018